Loading
Latest filing published 13 Mar 2009 for NEOPHARM INC, €418.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Laurence Birch across 2 companies, led by Neopharm Inc and Datatrak International Inc. In total, 9 filings cover trades dated from 14 May 2007 to 12 March 2009.
Every open-market trade on record is a purchase: 6 purchases worth €6,768, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants. So far in 2009, the count stands at 3 purchases and no sales.
A typical purchase (the median) is worth €471.
The record was last updated on 13 March 2009 with an open-market purchase (€418) in Neopharm Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations